[HTML] frontiersin.org

[HTML][HTML] Improvement of PD-1 blockade efficacy and elimination of immune-related gastrointestinal adverse effect by mTOR inhibitor

X Bai, X Wang, G Ma, J Song, X Liu, X Wu… - Frontiers in …, 2021 - frontiersin.org
During the past decades, immunotherapy, especially the antibody-mediated immune
checkpoint blockade (ICB) has shown durable tumor inhibition and changed the paradigm of …
被引用次数：17 相关文章

Improvement of PD-1 Blockade Efficacy and Elimination of Immune-Related Gastrointestinal Adverse Effect by mTOR Inhibitor.

X Bai, X Wang, G Ma, J Song, X Liu, X Wu… - Frontiers in …, 2021 - europepmc.org
During the past decades, immunotherapy, especially the antibody-mediated immune
checkpoint blockade (ICB) has shown durable tumor inhibition and changed the paradigm of …
[HTML] nih.gov

[HTML][HTML] Improvement of PD-1 Blockade Efficacy and Elimination of Immune-Related Gastrointestinal Adverse Effect by mTOR Inhibitor

X Bai, X Wang, G Ma, J Song, X Liu, X Wu… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
During the past decades, immunotherapy, especially the antibody-mediated immune
checkpoint blockade (ICB) has shown durable tumor inhibition and changed the paradigm of …

Improvement of PD-1 Blockade Efficacy and Elimination of Immune-Related Gastrointestinal Adverse Effect by mTOR Inhibitor

X Bai, X Wang, G Ma, J Song, X Liu… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
During the past decades, immunotherapy, especially the antibody-mediated immune
checkpoint blockade (ICB) has shown durable tumor inhibition and changed the paradigm of …

Improvement of PD-1 Blockade Efficacy and Elimination of Immune-Related Gastrointestinal Adverse Effect by mTOR Inhibitor.

X Bai, X Wang, G Ma, J Song, X Liu, X Wu… - Frontiers in …, 2021 - europepmc.org
During the past decades, immunotherapy, especially the antibody-mediated immune
checkpoint blockade (ICB) has shown durable tumor inhibition and changed the paradigm of …